These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 11246787

  • 1. Cost analysis of dialysis modalities in Italy.
    Tediosi F, Bertolini G, Parazzini F, Mecca G, Garattini L.
    Health Serv Manage Res; 2001 Feb; 14(1):9-17. PubMed ID: 11246787
    [Abstract] [Full Text] [Related]

  • 2. The cost of renal dialysis in a UK setting--a multicentre study.
    Baboolal K, McEwan P, Sondhi S, Spiewanowski P, Wechowski J, Wilson K.
    Nephrol Dial Transplant; 2008 Jun; 23(6):1982-9. PubMed ID: 18174268
    [Abstract] [Full Text] [Related]

  • 3. Health economic evaluations: the special case of end-stage renal disease treatment.
    Winkelmayer WC, Weinstein MC, Mittleman MA, Glynn RJ, Pliskin JS.
    Med Decis Making; 2002 Jun; 22(5):417-30. PubMed ID: 12365484
    [Abstract] [Full Text] [Related]

  • 4. Economic evaluation of centre haemodialysis and continuous ambulatory peritoneal dialysis in Ministry of Health hospitals, Malaysia.
    Hooi LS, Lim TO, Goh A, Wong HS, Tan CC, Ahmad G, Morad Z.
    Nephrology (Carlton); 2005 Feb; 10(1):25-32. PubMed ID: 15705178
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cost analysis of dialysis treatments for end-stage renal disease (ESRD).
    Goeree R, Manalich J, Grootendorst P, Beecroft ML, Churchill DN.
    Clin Invest Med; 1995 Dec; 18(6):455-64. PubMed ID: 8714789
    [Abstract] [Full Text] [Related]

  • 7. Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore.
    Yang F, Lau T, Luo N.
    Nephrology (Carlton); 2016 Aug; 21(8):669-77. PubMed ID: 26566750
    [Abstract] [Full Text] [Related]

  • 8. The economic cost of dialysis: a comparison between peritoneal dialysis and in-center hemodialysis in a Spanish unit.
    Rodríguez-Carmona A, Perez Fontán M, Bouza P, García Falcón T, Valdés F.
    Adv Perit Dial; 1996 Aug; 12():93-6. PubMed ID: 8865880
    [Abstract] [Full Text] [Related]

  • 9. Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: costs and reimbursement/funding of ESRD therapies.
    De Vecchi AF, Dratwa M, Wiedemann ME.
    Nephrol Dial Transplant; 1999 Aug; 14 Suppl 6():31-41. PubMed ID: 10528710
    [Abstract] [Full Text] [Related]

  • 10. A cost effectiveness analysis of the treatment of end stage renal failure.
    Croxson BE, Ashton T.
    N Z Med J; 1990 Apr 25; 103(888):171-4. PubMed ID: 2109846
    [Abstract] [Full Text] [Related]

  • 11. Lifetime cost-effectiveness analysis of first-line dialysis modalities for patients with end-stage renal disease under peritoneal dialysis first policy.
    Wong CKH, Chen J, Fung SKS, Mok M, Cheng YL, Kong I, Lo WK, Lui SL, Chan TM, Lam CLK.
    BMC Nephrol; 2020 Feb 04; 21(1):42. PubMed ID: 32019528
    [Abstract] [Full Text] [Related]

  • 12. Economic costs of automated and continuous ambulatory peritoneal dialysis in Taiwan: a combined survey and retrospective cohort analysis.
    Tang CH, Wu YT, Huang SY, Chen HH, Wu MJ, Hsu BG, Tsai JC, Chen TH, Sue YM.
    BMJ Open; 2017 Mar 21; 7(3):e015067. PubMed ID: 28325860
    [Abstract] [Full Text] [Related]

  • 13. An economic evaluation of hospital-based hemodialysis and home-based peritoneal dialysis for pediatric patients.
    Coyte PC, Young LG, Tipper BL, Mitchell VM, Stoffman PR, Willumsen J, Geary DF.
    Am J Kidney Dis; 1996 Apr 21; 27(4):557-65. PubMed ID: 8678067
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Economic evaluation of dialysis therapies.
    Klarenbach S, Manns B.
    Semin Nephrol; 2009 Sep 21; 29(5):524-32. PubMed ID: 19751898
    [Abstract] [Full Text] [Related]

  • 16. Cost-Utility Analysis of Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis for Thai Patients With End-Stage Renal Disease.
    Thaweethamcharoen T, Sritippayawan S, Noparatayaporn P, Aiyasanon N.
    Value Health Reg Issues; 2020 May 21; 21():181-187. PubMed ID: 32044691
    [Abstract] [Full Text] [Related]

  • 17. Direct and indirect costs of end-stage renal disease patients in the first and second years after initiation of nocturnal home haemodialysis, hospital haemodialysis and peritoneal dialysis.
    Wong CKH, Chen J, Fung SKS, Mok MMY, Cheng YL, Kong I, Lo WK, Lui SL, Chan TM, Lam CLK.
    Nephrol Dial Transplant; 2019 Sep 01; 34(9):1565-1576. PubMed ID: 30668781
    [Abstract] [Full Text] [Related]

  • 18. Costs and added value of haemodialysis and peritoneal dialysis outsourcing agreements.
    Lamas Barreiro JM, Alonso Suárez M, Saavedra Alonso JA, Gándara Martínez A.
    Nefrologia; 2011 Sep 01; 31(6):656-63. PubMed ID: 22130280
    [Abstract] [Full Text] [Related]

  • 19. Hemodialysis versus peritoneal dialysis, which is cost-effective?
    Atapour A, Eshaghian A, Taheri D, Dolatkhah S.
    Saudi J Kidney Dis Transpl; 2015 Sep 01; 26(5):962-5. PubMed ID: 26354569
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.